Amicus Therapeutics Inc (NASDAQ:FOLD) price on current trading day, rose 2.69% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $6.11.
A look at the stock’s price movement, the level at last check in today’s session was $5.95, moving within a range at $5.97 and $6.11. The beta value (5-Year monthly) was 0.525. Turning to its 52-week performance, $12.65 and $5.51 were the 52-week high and 52-week low respectively. Overall, FOLD moved -2.40% over the past month.
Amicus Therapeutics Inc’s market cap currently stands at around $1.88 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-01.
Turning to the stock’s technical picture we see that short term indicators suggest on average that FOLD is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend FOLD as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
FOLD’s current price about 3.43% and -2.11% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 53.35, while 7-day volatility ratio is 4.41% and 3.63% in the 30-day chart. Further, Amicus Therapeutics Inc (FOLD) has a beta value of 0.52. Analysts have given the company’s stock an average 52-week price target of $14.5, forecast between a low of $13 and high of $19. Looking at the price targets, the low is -112.77% off recent price level in today’s trading while to achieve the yearly target high, it has to move -210.97%. Nonetheless, investors will most likely welcome a -137.32% jump to $14.5 which is the analysts’ median price.
If we refocus on Amicus Therapeutics Inc (NASDAQ:FOLD), historical trading data shows that trading volumes averaged 6.39 over the past 10 days and 5.11 million over the past 3 months. The company’s latest data on shares outstanding shows there are 307.92 million shares.
The 3.51% of Amicus Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 99.78% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 20.9 million on 2025-06-13, giving us a short ratio of 4.7. The data shows that as of 2025-06-13 short interest in Amicus Therapeutics Inc (FOLD) stood at 683.0 of shares outstanding, with shares short rising to 20.18 million registered in 2025-05-15. Current price change has pushed the stock -37.65% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the FOLD stock continues to rise going into the next quarter.
